Anondita Medicare IPO Subscription Status

The Anondita Medicare IPO witnessed strong investor demand, being subscribed 40.85 times on its second day of bidding till 5:00 PM on August 25, 2025.

• QIB (Qualified Institutional Buyers): 2.17x
• NII (Non-Institutional Investors): 56.73x
• RII (Retail Individual Investors): 56.13x

In total, the company received bids for 12,96,21,000 shares against 31,73,000 shares on offer.

• On Day 1, the issue was subscribed 3.40x.
• On Day 2, it jumped sharply to 40.85x, showing very high demand, especially from retail and HNI investors.

About Anondita Medicare Limited

Incorporated in March 2024, Anondita Medicare Limited is a fast-growing healthcare company primarily engaged in the manufacturing of flavored male condoms under its flagship brand “COBRA.”

• The company has a robust annual production capacity of 562 million condoms.
• Its manufacturing facilities are located in Noida, Uttar Pradesh, equipped with modern technology and quality control systems.
• Products are exported to multiple international markets including Southeast Asia, Africa, and the Middle East.
• The company works in collaboration with global health organizations, NGOs, and government bodies to promote family planning, sexual health awareness, and public health initiatives.

Anondita Medicare has also built a strong distribution network, partnering with wholesalers, retailers, and e-commerce platforms to make its products easily accessible. Additionally, the company actively supports government health programs by supplying essential contraceptives and other medical products.

As of July 31, 2025, the company has a workforce of 280 employees dedicated to production, R&D, and distribution.

Anondita Medicare Financial Report

• Revenue (FY 2025): ₹77.13 crore (vs ₹46.56 crore in FY 2024)
• Profit (FY 2025): ₹16.42 crore (vs ₹3.84 crore in FY 2024)
• The company has shown 67% YoY revenue growth and a 4x increase in profitability, highlighting strong operational efficiency and rising market demand.

Anondita Medicare IPO GMP (Grey Market Premium)

As of Monday, August 25, 2025, the GMP stood at ₹65.

• This implies that shares are trading at ₹210 in the grey market, which is a ₹65 premium over the issue price of ₹145.
• The strong subscription numbers and premium in the grey market reflect investor confidence in the company’s business model and growth outlook.